Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2022

Mar 17, 2022

33728_dirs_2022-03-17_551f623a-d8f8-47ba-8857-f8e22bf31e36.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-03-15

Reporting Person: McGaughy R Kent Jr (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-15 Common Stock J 260323 Disposed 8218467 Indirect

Footnotes

F1: The securities are held by Ibisbill, LP (the "LP"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the shares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to share voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial ownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein.

F2: The LP distributed these shares to its partners on a pro rata basis, for no consideration.